Get the Stockscreener App
0.72
4.28%
-0.0322
After Hours:
.72
Matinas Biopharma Holdings Inc stock is traded at $0.72, with a volume of 24,918.
It is down -4.28% in the last 24 hours and up +16.22% over the past month.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. The company's lead anti-fungal product candidate is MAT2203, an orally-administered cochleate formulation of amphotericin B that has completed Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients with acute lymphoblastic leukemia. Its product candidates also comprise MAT2501, an orally administered cochleate formulation of the broad spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. The company was founded in 2013 and is based in Bedminster, New Jersey.
See More
Previous Close:
$0.7522
Open:
$0.75
24h Volume:
24,918
Relative Volume:
0.81
Market Cap:
$4.61M
Revenue:
-
Net Income/Loss:
$-21.13M
P/E Ratio:
-0.1503
EPS:
-4.79
Net Cash Flow:
$-16.95M
1W Performance:
+12.96%
1M Performance:
+16.22%
6M Performance:
-22.59%
1Y Performance:
+14.67%
1-Day Range:
$0.7101
$0.75
1-Week Range:
$0.5673
$0.7899
52-Week Range:
$0.4748
$3.09
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Name
Matinas Biopharma Holdings Inc
Sector
Industry
Phone
908-443-1860
Address
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.72 | 4.82M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-11-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-26-20 | Resumed | Piper Sandler | Overweight |
| Jan-27-20 | Initiated | Piper Sandler | Overweight |
| Jan-24-20 | Initiated | SunTrust | Buy |
| Jan-23-20 | Initiated | SunTrust | Buy |
| Jan-09-20 | Initiated | Aegis Capital | Buy |
| Jun-26-19 | Initiated | H.C. Wainwright | Buy |
View All
Matinas Biopharma Holdings Inc Stock (MTNB) Latest News
Matinas BioPharma appoints CEO Jerome Jabbour as interim CFO By Investing.com - Investing.com Nigeria
Matinas BioPharma appoints CEO Jerome Jabbour as interim CFO - Investing.com
Matinas BioPharma CEO Named Interim Chief Financial Officer - TipRanks
Buyback Watch: Is STNG undervalued by DCF analysisBuy Signal & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Matinas Biopharma Holdings Inc Keith Kucinski Resigns As CFO Effective January 17, 2026 - TradingView
Trend Report: Is Matinas BioPharma Holdings Inc stock heavily shortedNew Guidance & Weekly High Conviction Ideas - baoquankhu1.vn
Valuation Update: What is CRVSs book value per share2025 Year in Review & Daily Market Momentum Tracking - baoquankhu1.vn
Exit Recap: Is Matinas BioPharma Holdings Inc stock heavily shortedJuly 2025 Short Interest & Weekly High Return Stock Opportunities - baoquankhu1.vn
Sectors Review: Will Mega Matrix Inc stock maintain momentum in 2025Weekly Risk Summary & Verified Chart Pattern Trade Signals - Bộ Nội Vụ
MSN Money - MSN
Will Matinas Biopharma Holdings Inc. stock announce special dividend2025 Market Sentiment & AI Forecasted Stock Moves - Улправда
How Matinas Biopharma Holdings Inc. stock trades pre earningsJuly 2025 Chart Watch & Long Hold Capital Preservation Tips - ulpravda.ru
How Matinas BioPharma Holdings Inc. stock performs in weak economyEarnings Risk Summary & Consistent Growth Equity Picks - ulpravda.ru
2026 world cup canada qualification young talents counter attacking knockout prediction insights2025 Risk Factors & Fast Gain Swing Alerts - Улправда
2026 world cup canada quarterfinals best goals insightsMarket Performance Summary & Free Accurate Trade Setup Notifications - Улправда
Is Sprout Social Inc. stock a dividend growth opportunityMarket Performance Report & Technical Analysis for Trade Confirmation - Улправда
Will Enpro Inc. stock attract ESG investorsQuarterly Market Review & Community Trade Idea Sharing - ulpravda.ru
Will Matinas BioPharma Holdings Inc. stock reach all time highs in 2025 - Улправда
Will Matinas BioPharma Holdings Inc. stock deliver strong dividend growth2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - ulpravda.ru
How currency fluctuations impact Toppoint Holdings Inc. stockQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - ulpravda.ru
Will Matinas BioPharma Holdings Inc. stock outperform growth indexesQuarterly Trade Summary & Free Reliable Trade Execution Plans - Улправда
2026 world cup usa round of 32 defensive leaders set piece tactics match prediction insightsInflation Watch & Weekly Watchlist for Hot Stocks - Улправда
Analyst Upgrade: Is Matinas BioPharma Holdings Inc. stock a defensive play in 20252025 Fundamental Recap & Weekly Chart Analysis and Trade Guides - Bộ Nội Vụ
US Market Wrap: Will Wetouch Technology Inc stock rally after Fed decisions2025 Year in Review & High Accuracy Swing Entry Alerts - moha.gov.vn
Ventive Hospitality Limited Building a Base Near SupportMACD Histogram Signals & Avoid Market Traps With Pro-Level Warnings - bollywoodhelpline.com
Indrayani Biotech Limited Recovery Gathers Momentum on Chart SignalsInflation Impact on Stocks & Breakout Portfolio Performance - bollywoodhelpline.com
Is Now a Good Time to Reenter Relic Technologies LimitedInstitutional Buying Trends & Low Entry Cost Trading - bollywoodhelpline.com
Is It Too Late to Sell TCM LimitedDividend Stability Analysis & Free Dynamic Capital Growth - bollywoodhelpline.com
Holdings Limited RecoverySwing Trading Watchlist & Free Navigate Market With Precision - bollywoodhelpline.com
Will Matinas BioPharma Holdings Inc. (6LJ0) stock sustain uptrend momentumPortfolio Return Report & High Conviction Investment Ideas - Улправда
Can Matinas BioPharma Holdings Inc. stock beat market expectations this quarter2025 Big Picture & Verified Trade Idea Suggestions - Улправда
Breakout Watch: Can Matinas BioPharma Holdings Inc. stock beat market expectations this quarterPortfolio Performance Report & Capital Efficiency Focused Ideas - Улправда
Is Matinas BioPharma Holdings Inc. stock supported by innovation pipelinePortfolio Value Report & Real-Time Sentiment Analysis - DonanımHaber
Trading Recap: Will Matinas BioPharma Holdings Inc. stock benefit from sector rotationJuly 2025 Volume & Weekly High Momentum Picks - ulpravda.ru
Matinas BioPharma amends CEO employment agreement to revise retention bonus terms - Investing.com Canada
Matinas BioPharma Amends CEO Employment Agreement - The Globe and Mail
Matinas BioPharma amends CEO employment agreement to revise retention bonus terms By Investing.com - Investing.com South Africa
Matinas BioPharma (NYSE: MTNB) amends CEO contract with extended change-in-control bonus protections - Stock Titan
Matinas BioPharma CFO Resignation Announced - MSN
Forecast Cut: Will Matinas BioPharma Holdings Inc stock gain from strong economyMarket Rally & AI Enhanced Market Trend Forecasts - BỘ NỘI VỤ
How Matinas Biopharma Holdings Inc. stock reacts to stronger dollarJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - Newser
What insider trading reveals about Matinas BioPharma Holdings Inc. stockQuarterly Market Review & Accurate Buy Signal Notifications - Newser
Why Matinas Biopharma Holdings Inc. stock attracts wealthy investorsPortfolio Gains Report & Proven Capital Preservation Methods - Newser
Will Matinas BioPharma Holdings Inc. stock gain from strong economyEarnings Beat & Free Low Drawdown Momentum Trade Ideas - Newser
Will Matinas Biopharma Holdings Inc. stock sustain uptrend momentum2025 Year in Review & Fast Entry and Exit Trade Plans - Newser
How Matinas BioPharma Holdings Inc. (6LJ0) stock reacts to new regulationsTake Profit & Intraday High Probability Setup Alerts - Newser
Is Matinas Biopharma Holdings Inc. stock a top hedge fund pickOil Prices & High Return Trade Opportunity Guides - Newser
Why Matinas Biopharma Holdings Inc. stock benefits from AI revolutionQuarterly Profit Review & Risk Adjusted Buy and Sell Alerts - Newser
Matinas Biopharma Holdings Inc Stock (MTNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.09%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):